| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |